Table 1.
Drugs | IC50 Values (µM, Mean ± SEM) | |||||
---|---|---|---|---|---|---|
MCF-7 | MDA-MB-231 | HCC-1806 | MDA-MB-468 | BT-549 | BT-20 | |
PTX | 0.012 ± 0.003 | 1.473 ± 0.014 | 0.008 ± 0.002 | 0.004 ± 0.001 | 0.015 ± 0.007 | 0.012 ± 0.004 |
YM | 0.019 ± 0.004 | 0.004 ± 0.001 | 0.018 ± 0.002 | 0.002 ± 0.001 | 0.025 ± 0.001 | 0.001 ± 0.001 |
PNB | 0.058 ± 0.022 | 0.084 ± 0.014 | 0.016 ± 0.004 | 0.002 ± 0.001 | 0.144 ± 0.007 | 0.084 ± 0.032 |
VS | 0.193 ± 0.078 | 9.365 ± 4.329 | --- | --- | --- | --- |
NCS * | 0.373 ± 0.097 | 0.545 ± 0.024 | 3.106 ± 0.101 | 1.878 ± 0.458 | 0.960 ± 0.034 | 1.547 ± 0.062 |
FLU | 0.787 ± 0.110 | 17.87 ± 1.300 | 0.402 ± 0.130 | 0.001 ± 0.001 | 0.504 ± 0.049 | 0.041 ± 0.003 |
NTC | 1.055 ± 0.166 | 1.314 ± 0.159 | --- | --- | --- | --- |
DSF | 1.182 ± 0.152 | 11.65 ± 0.253 | --- | --- | --- | --- |
SAL * | 2.702 ± 0.107 | 0.399 ± 0.149 | --- | --- | --- | --- |
DFT | 3.242 ± 1.180 | 32.10 ± 1.720 | --- | --- | --- | --- |
8Q * | 4.442 ± 0.137 | 25.55 ± 0.151 | 25.19 ± 1.08 | 3.295 ± 0.111 | 79.74 ± 2.890 | 16.15 ± 0.67 |
EVE | 10.38 ± 0.591 | 13.21 ± 1.449 | --- | --- | --- | --- |
GLA | 21.71 ± 4.367 | 18.72 ± 5.362 | --- | --- | --- | --- |
ISO | 25.11 ± 0.724 | 53.33 ± 5.275 | --- | --- | --- | --- |
6-SHO | 27.73 ± 1.597 | 24.08 ± 2.995 | --- | --- | --- | --- |
MET | 3523 ± 601 | 3315 ± 396 | --- | --- | --- | --- |
ACE | 4670 ± 417 | 6806 ± 842 | --- | --- | --- | --- |
CIT | >200 | >200 | --- | --- | --- | --- |
Drug abbreviations stand for: PTX, paclitaxel; YM, YM-155 hydrocloride; PNB, panobinostat; VS, VS-5584; NCS, niclosamide; FLU, flubendazole; NTC, nitidine chloride; DSF, disulfiram; SAL, salimomycin; DFT, defactinib; 8Q, 8-quinolinol; EVE, everolimus; GLA, glabridin; ISO, isoliquiritigenin; 6-SHO, 6-shogaol; MET, metformin hydrochloride; ACE, acetaminophen; CIT, citral. Compounds proceeding into further assays are labeled with an asterisk *.